AVBP Financials

ArriVent BioPharma, Inc. Common Stock - Financial statements & key metrics

Stock Price

$29.79

Market Cap

$1.39B

P/E Ratio

-11.6

EPS

$-4.15

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-80.49M

EPS (Diluted)

$-2.56

Balance Sheet Highlights

Total Assets

$274.94M

Total Liabilities

$17.29M

Shareholders Equity

Cash & Equivalents

$5,000

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-70.21M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-51.8%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is AVBP revenue?

View AVBP's income statement for detailed revenue data.

Is AVBP profitable?

AVBP reported a loss of $80.49M in the most recent quarter.

What is AVBP market cap?

AVBP has a market capitalization of $1.39B, making it a small-cap stock.

Does AVBP have debt?

View AVBP's balance sheet for debt information.

What is AVBP cash flow?

Cash flow data is available in the full financial statements.